How to Buy polymed Shares on Fincept?
You can buy Poly Medicure Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Poly Medicure Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Polymed, including updates on board meetings and corporate actions.
Poly Medicure Limited - https://www.polymedicure.com
Poly Medicure Limited manufactures and sells medical devices in India and internationally. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal and tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. It offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. The company provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, ESR pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, universal caps, and ECG electrodes. The company was incorporated in 1995 and is based in New Delhi, India.
Poly Medicure Limited Share Price Today
2,269.10
OPEN
2,367.05
HIGH
2,214.00
LOW
2,304.30
CLOSE
116 K
VOLUME
25,980 Cr
Market Cap
212286
Average Volume
Healthcare
Sector
NSI
Exchange
Poly Medicure Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: POLYMED Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Poly Medicure Limited |
POLYMED |
INE205C01013 |
Annual General Meeting/Dividend - Rs 3 Per Share |
19 Sep 2024 |
5 |
N/A |
Poly Medicure Limited |
POLYMED |
INE205C01013 |
Annual General Meeting/Dividend - Rs 3 Per Share |
21 Sep 2023 |
5 |
N/A |
Poly Medicure Limited |
POLYMED |
INE205C01013 |
Annual General Meeting/Dividend - Rs 2.50 Per Share |
16 Sep 2022 |
5 |
N/A |
Poly Medicure Limited |
POLYMED |
INE205C01013 |
Dividend - Rs 2.50 Per Share |
16 Sep 2021 |
5 |
N/A |
Poly Medicure Limited |
POLYMED |
INE205C01013 |
Annual General Meeting |
16 Sep 2021 |
5 |
N/A |
NSE: POLYMED Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
POLYMED |
31 Dec 2024, 15:54:51 |
Trading Window-XBRL |
Pharmaceuticals |
POLYMED |
31 Dec 2024, 15:53:51 |
Trading Window |
Pharmaceuticals |
POLYMED |
24 Dec 2024, 18:25:18 |
Notice Of Shareholders Meetings-XBRL |
Pharmaceuticals |
POLYMED |
24 Dec 2024, 18:00:50 |
Shareholders meeting |
Pharmaceuticals |
POLYMED |
02 Dec 2024, 17:25:12 |
Loss/Duplicate-Share Certificate-XBRL |
Pharmaceuticals |
NSE: POLYMED Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Poly Medicure Limited |
POLYMED |
12 Nov 2024, 12:28:00 |
12 Nov 2024, 12:28:00 |
|
Poly Medicure Limited |
POLYMED |
11 Nov 2024, 15:29:00 |
11 Nov 2024, 15:30:00 |
|
Poly Medicure Limited |
POLYMED |
19 Oct 2024, 17:10:00 |
19 Oct 2024, 17:10:00 |
|
Poly Medicure Limited |
POLYMED |
12 Nov 2024, 08:24:00 |
12 Nov 2024, 08:24:00 |
|
Poly Medicure Limited |
POLYMED |
19 Jul 2024, 17:58:00 |
19 Jul 2024, 17:58:00 |
NSE: POLYMED Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson & Non-Executive Director |
25 Jun 1937 |
23 Sep 2014 |
01067895 |
DEVENDRA RAJ MEHTA |
Active |
Executive Director-MD |
08 Jun 1968 |
01 Apr 1995 |
00014008 |
HIMANSHU BAID |
Active |
Executive Director |
02 Jun 1972 |
01 Apr 1995 |
00048585 |
RISHI BAID |
Active |
Non-Executive Director |
30 Mar 1942 |
20 May 1995 |
00077347 |
JUGAL KISHORE BAID |
Active |
Non-Executive Director |
27 Sep 1949 |
30 Jul 2014 |
02900103 |
MUKULIKA BAID |
Active |
NSE: POLYMED Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
POLY MEDICURE LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and ESOP/Other business. |
POLYMED |
N/A |
INE205C01013 |
Poly Medicure Limited |
19 Oct 2024, 17:48:33 |
Financial Results/Other business matters |
POLYMED |
N/A |
INE205C01013 |
Poly Medicure Limited |
17 Jul 2024, 19:09:24 |
Fund Raising/Other business matters |
POLYMED |
N/A |
INE205C01013 |
Poly Medicure Limited |
25 Jun 2024, 18:45:36 |
POLY MEDICURE LIMITED has informed the Exchange about Board Meeting to be held on 17-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
POLYMED |
N/A |
INE205C01013 |
Poly Medicure Limited |
02 May 2024, 17:54:23 |
POLY MEDICURE LIMITED has informed the Exchange about Board Meeting to be held on 08-Mar-2024 to consider and approve Fund raising/Other business. |
POLYMED |
N/A |
INE205C01013 |
Poly Medicure Limited |
04 Mar 2024, 12:51:03 |
NSE: POLYMED Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results/Other business matters |
POLYMED |
- |
INE205C01013 |
Poly Medicure Limited |
19 Oct 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
Financial Results/Other business matters |
POLYMED |
- |
INE205C01013 |
Poly Medicure Limited |
17 Jul 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
Fund Raising/Other business matters |
POLYMED |
- |
INE205C01013 |
Poly Medicure Limited |
25 Jun 2024, 00:00:00 |
To consider Fund Raising and other business matters |
Financial Results/Dividend/Other business matters |
POLYMED |
- |
INE205C01013 |
Poly Medicure Limited |
02 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters |
Fund Raising/Other business matters |
POLYMED |
- |
INE205C01013 |
Poly Medicure Limited |
04 Mar 2024, 00:00:00 |
To consider Fund Raising and other business matters |
NSE: POLYMED Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Revenue | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Deferred Taxes Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Investmentin Financial Assets | Available For Sale Securities | Financial Assets Designatedas Fair Value Through Profitor Loss | Long Term Equity Investment | Investmentsin Associatesat Cost | Investment Properties | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Restricted Cash | Prepaid Assets | Inventory | Other Inventories | Finished Goods | Work In Process | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 101,290,565.00 | 101,290,565.00 | 1,445,085,000.00 | 1,606,277,000.00 | 25,361,235,000.00 | 27,488,576,000.00 | 15,070,511,000.00 | 25,361,235,000.00 | 30,331,000.00 | 25,912,630,000.00 | 25,923,787,000.00 | 25,912,630,000.00 | 0.00 | 25,912,630,000.00 | 25,406,177,000.00 | 0.00 | 0.00 | 506,453,000.00 | 506,453,000.00 | 4,610,006,000.00 | 440,061,000.00 | 0.00 | 0.00 | 20,310,000.00 | 289,048,000.00 | 23,526,000.00 | 12,369,000.00 | 11,157,000.00 | 99,723,000.00 | 4,169,945,000.00 | 233,159,000.00 | 0.00 | 1,582,751,000.00 | 17,962,000.00 | 1,564,789,000.00 | 0.00 | 8,343,000.00 | 1,501,478,000.00 | 0.00 | 0.00 | 50,910,000.00 | 1,450,568,000.00 | 30,522,636,000.00 | 11,282,182,000.00 | 495,761,000.00 | 0.00 | 348,630,000.00 | 348,630,000.00 | 0.00 | 94,260,000.00 | 0.00 | 0.00 | 551,395,000.00 | 265,584,000.00 | 285,811,000.00 | 9,792,136,000.00 | 0.00 | 9,792,136,000.00 | 623,599,000.00 | 9,168,537,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 19,240,456,000.00 | 612,986,000.00 | 0.00 | 0.00 | 2,698,370,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,838,000.00 | 0.00 | 3,283,713,000.00 | 0.00 | 0.00 | 12,641,549,000.00 | 12,510,688,000.00 | 130,861,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 95,971,417.00 | 95,971,417.00 | 1,570,734,000.00 | 1,730,642,000.00 | 14,164,779,000.00 | 16,391,800,000.00 | 4,903,852,000.00 | 14,164,779,000.00 | 39,377,000.00 | 14,700,535,000.00 | 14,700,535,000.00 | 14,700,535,000.00 | 0.00 | 14,700,535,000.00 | 34,001,000.00 | 7,308,518,000.00 | 3,933,251,000.00 | 479,858,000.00 | 479,858,000.00 | 3,886,184,000.00 | 373,769,000.00 | 11,223,000.00 | 59,898,000.00 | 30,004,000.00 | 244,834,000.00 | 20,870,000.00 | 20,870,000.00 | 0.00 | 59,898,000.00 | 3,512,415,000.00 | 283,895,000.00 | 35,597,000.00 | 1,709,772,000.00 | 18,507,000.00 | 1,691,265,000.00 | 334,657,000.00 | 5,719,000.00 | 1,307,426,000.00 | 347,325,000.00 | 4,125,000.00 | 35,597,000.00 | 955,976,000.00 | 18,586,719,000.00 | 10,170,452,000.00 | -1,000.00 | 67,213,000.00 | 275,368,000.00 | 70,953,000.00 | 204,415,000.00 | 71,287,000.00 | 71,287,000.00 | 5,837,000.00 | 535,756,000.00 | 249,945,000.00 | 285,811,000.00 | 9,209,886,000.00 | -4,213,366,000.00 | 13,423,252,000.00 | 987,497,000.00 | 37,110,000.00 | 8,624,252,000.00 | 2,406,954,000.00 | 1,367,439,000.00 | 0.00 | 8,416,267,000.00 | 178,484,000.00 | 4,125,000.00 | 152,570,000.00 | 2,210,304,000.00 | 141,987,000.00 | 280,555,000.00 | 452,576,000.00 | 1,335,186,000.00 | 138,767,000.00 | 172,761,000.00 | 2,699,388,000.00 | -29,917,000.00 | 2,729,305,000.00 | 2,859,868,000.00 | 2,739,337,000.00 | 120,531,000.00 | 0.00 | 120,531,000.00 |
| 2024-03-31T00:00:00 | annual | 95,971,417.00 | 95,971,417.00 | 1,570,734,000.00 | 1,730,642,000.00 | 14,164,779,000.00 | 16,391,800,000.00 | 4,903,852,000.00 | 14,164,779,000.00 | 39,377,000.00 | 14,700,535,000.00 | 14,700,535,000.00 | 14,700,535,000.00 | 0.00 | 14,700,535,000.00 | 34,001,000.00 | 7,308,518,000.00 | 3,933,251,000.00 | 479,858,000.00 | 479,858,000.00 | 3,886,184,000.00 | 373,769,000.00 | 11,223,000.00 | 59,898,000.00 | 30,004,000.00 | 244,834,000.00 | 20,870,000.00 | 20,870,000.00 | 0.00 | 59,898,000.00 | 3,512,415,000.00 | 283,895,000.00 | 35,597,000.00 | 1,709,772,000.00 | 18,507,000.00 | 1,691,265,000.00 | 334,657,000.00 | 5,719,000.00 | 1,307,426,000.00 | 347,325,000.00 | 4,125,000.00 | 35,597,000.00 | 955,976,000.00 | 18,586,719,000.00 | 10,170,452,000.00 | -1,000.00 | 67,213,000.00 | 275,368,000.00 | 70,953,000.00 | 204,415,000.00 | 71,287,000.00 | 71,287,000.00 | 5,837,000.00 | 535,756,000.00 | 249,945,000.00 | 285,811,000.00 | 9,209,886,000.00 | -4,213,366,000.00 | 13,423,252,000.00 | 987,497,000.00 | 37,110,000.00 | 8,624,252,000.00 | 2,406,954,000.00 | 1,367,439,000.00 | 0.00 | 8,416,267,000.00 | 178,484,000.00 | 4,125,000.00 | 152,570,000.00 | 2,210,304,000.00 | 141,987,000.00 | 280,555,000.00 | 452,576,000.00 | 1,335,186,000.00 | 138,767,000.00 | 172,761,000.00 | 2,699,388,000.00 | -29,917,000.00 | 2,729,305,000.00 | 2,859,868,000.00 | 2,739,337,000.00 | 120,531,000.00 | 0.00 | 120,531,000.00 |
| 2023-09-30T00:00:00 | quarterly | 95,944,342.00 | 95,944,342.00 | 1,209,892,000.00 | 1,351,246,000.00 | 12,839,396,000.00 | 14,711,758,000.00 | 4,914,035,000.00 | 12,839,396,000.00 | 19,799,000.00 | 13,380,311,000.00 | 13,484,418,000.00 | 13,380,311,000.00 | 0.00 | 13,380,311,000.00 | 12,900,588,000.00 | 0.00 | 0.00 | 479,723,000.00 | 479,723,000.00 | 3,591,450,000.00 | 381,937,000.00 | 0.00 | 0.00 | 24,360,000.00 | 175,756,000.00 | 111,004,000.00 | 6,897,000.00 | 104,107,000.00 | 66,121,000.00 | 3,209,513,000.00 | 270,023,000.00 | 0.00 | 1,240,242,000.00 | 12,902,000.00 | 1,227,340,000.00 | 0.00 | 6,922,000.00 | 971,683,000.00 | 0.00 | 0.00 | 25,617,000.00 | 946,066,000.00 | 16,971,761,000.00 | 8,848,213,000.00 | 406,046,000.00 | 0.00 | 349,087,000.00 | 349,087,000.00 | 0.00 | 96,128,000.00 | 0.00 | 9,008,000.00 | 540,915,000.00 | 255,104,000.00 | 285,811,000.00 | 7,447,029,000.00 | 0.00 | 7,447,029,000.00 | 955,719,000.00 | 6,491,310,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8,123,548,000.00 | 518,714,000.00 | 0.00 | 0.00 | 2,133,088,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,827,000.00 | 0.00 | 2,524,473,000.00 | 0.00 | 0.00 | 2,944,446,000.00 | 2,822,891,000.00 | 121,555,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 95,944,342.00 | 95,944,342.00 | 1,393,715,000.00 | 1,490,168,000.00 | 11,914,974,000.00 | 13,880,611,000.00 | 5,133,851,000.00 | 11,914,974,000.00 | 25,829,000.00 | 12,416,272,000.00 | 12,591,284,000.00 | 12,416,272,000.00 | 0.00 | 12,416,272,000.00 | 23,053,000.00 | 5,277,486,000.00 | 3,924,045,000.00 | 479,723,000.00 | 479,723,000.00 | 3,355,820,000.00 | 422,794,000.00 | 1,000.00 | 46,023,000.00 | 27,352,000.00 | 154,347,000.00 | 188,505,000.00 | 13,493,000.00 | 175,012,000.00 | 46,023,000.00 | 2,933,026,000.00 | 3,000.00 | 8,376,000.00 | 1,301,663,000.00 | 12,336,000.00 | 1,289,327,000.00 | 256,854,000.00 | 5,520,000.00 | 1,145,281,000.00 | 218,441,000.00 | 3,692,000.00 | 8,376,000.00 | 923,148,000.00 | 15,772,092,000.00 | 7,705,215,000.00 | -2,000.00 | 51,635,000.00 | 67,386,000.00 | 67,386,000.00 | 0.00 | 76,420,000.00 | 76,420,000.00 | 9,089,000.00 | 501,298,000.00 | 215,487,000.00 | 285,811,000.00 | 6,993,848,000.00 | -3,663,945,000.00 | 10,657,793,000.00 | 1,095,902,000.00 | 24,738,000.00 | 6,870,074,000.00 | 1,672,729,000.00 | 994,350,000.00 | 0.00 | 8,066,877,000.00 | 261,968,000.00 | 3,692,000.00 | 192,865,000.00 | 2,086,548,000.00 | 80,792,000.00 | 512,826,000.00 | 335,641,000.00 | 1,157,289,000.00 | 72,621,000.00 | 81,988,000.00 | 2,354,320,000.00 | -18,785,000.00 | 2,373,105,000.00 | 3,012,875,000.00 | 2,942,251,000.00 | 70,624,000.00 | 0.00 | 70,624,000.00 |
| 2023-03-31T00:00:00 | annual | 95,944,342.00 | 95,944,342.00 | 1,393,715,000.00 | 1,490,168,000.00 | 11,914,974,000.00 | 13,880,611,000.00 | 5,133,851,000.00 | 11,914,974,000.00 | 25,829,000.00 | 12,416,272,000.00 | 12,591,284,000.00 | 12,416,272,000.00 | 0.00 | 12,416,272,000.00 | 23,053,000.00 | 5,277,486,000.00 | 3,924,045,000.00 | 479,723,000.00 | 479,723,000.00 | 3,355,820,000.00 | 422,794,000.00 | 1,000.00 | 46,023,000.00 | 27,352,000.00 | 154,347,000.00 | 188,505,000.00 | 13,493,000.00 | 175,012,000.00 | 46,023,000.00 | 2,933,026,000.00 | 3,000.00 | 8,376,000.00 | 1,301,663,000.00 | 12,336,000.00 | 1,289,327,000.00 | 256,854,000.00 | 5,520,000.00 | 1,145,281,000.00 | 218,441,000.00 | 3,692,000.00 | 8,376,000.00 | 923,148,000.00 | 15,772,092,000.00 | 7,705,215,000.00 | -2,000.00 | 51,635,000.00 | 67,386,000.00 | 67,386,000.00 | 0.00 | 76,420,000.00 | 76,420,000.00 | 9,089,000.00 | 501,298,000.00 | 215,487,000.00 | 285,811,000.00 | 6,993,848,000.00 | -3,663,945,000.00 | 10,657,793,000.00 | 1,095,902,000.00 | 24,738,000.00 | 6,870,074,000.00 | 1,672,729,000.00 | 994,350,000.00 | 0.00 | 8,066,877,000.00 | 261,968,000.00 | 3,692,000.00 | 192,865,000.00 | 2,086,548,000.00 | 80,792,000.00 | 512,826,000.00 | 335,641,000.00 | 1,157,289,000.00 | 72,621,000.00 | 81,988,000.00 | 2,354,320,000.00 | -18,785,000.00 | 2,373,105,000.00 | 3,012,875,000.00 | 2,942,251,000.00 | 70,624,000.00 | 0.00 | 70,624,000.00 |
| 2022-03-31T00:00:00 | annual | 95,900,342.00 | 95,900,342.00 | 1,175,171,000.00 | 1,267,084,000.00 | 10,368,260,000.00 | 12,127,559,000.00 | 5,567,583,000.00 | 10,368,260,000.00 | 14,339,000.00 | 10,874,814,000.00 | 11,256,086,000.00 | 10,874,814,000.00 | 0.00 | 10,874,814,000.00 | 15,251,000.00 | 3,990,412,000.00 | 3,912,701,000.00 | 479,502,000.00 | 479,502,000.00 | 2,893,533,000.00 | 626,750,000.00 | -1,000.00 | 39,822,000.00 | 35,292,000.00 | 161,334,000.00 | 385,068,000.00 | 3,796,000.00 | 381,272,000.00 | 39,822,000.00 | 2,266,783,000.00 | 230,711,000.00 | 0.00 | 882,016,000.00 | 10,543,000.00 | 871,473,000.00 | 202,486,000.00 | 3,479,000.00 | 1,052,412,000.00 | 158,396,000.00 | 3,627,000.00 | 0.00 | 890,389,000.00 | 13,768,347,000.00 | 5,933,981,000.00 | 1,000.00 | 329,256,000.00 | 188,279,000.00 | 188,279,000.00 | 0.00 | 97,688,000.00 | 97,688,000.00 | 38,688,000.00 | 506,554,000.00 | 220,743,000.00 | 285,811,000.00 | 4,769,695,000.00 | -3,182,435,000.00 | 7,952,130,000.00 | 371,356,000.00 | 11,520,000.00 | 5,820,369,000.00 | 985,570,000.00 | 763,315,000.00 | 0.00 | 7,834,366,000.00 | 230,680,000.00 | 3,627,000.00 | 156,196,000.00 | 1,683,643,000.00 | 110,508,000.00 | 326,638,000.00 | 256,159,000.00 | 990,338,000.00 | 87,124,000.00 | 90,103,000.00 | 2,066,289,000.00 | -3,790,000.00 | 2,070,079,000.00 | 3,516,704,000.00 | 3,439,130,000.00 | 77,574,000.00 | 0.00 | 77,574,000.00 |
| 2021-03-31T00:00:00 | annual | 95,880,567.00 | 95,880,567.00 | 1,280,951,000.00 | 1,363,395,000.00 | 9,141,619,000.00 | 10,986,202,000.00 | 5,327,117,000.00 | 9,141,619,000.00 | 32,898,000.00 | 9,655,705,000.00 | 10,277,620,000.00 | 9,655,705,000.00 | 0.00 | 9,655,705,000.00 | 7,863,000.00 | 3,041,653,000.00 | 3,913,379,000.00 | 479,403,000.00 | 479,403,000.00 | 2,581,600,000.00 | 867,634,000.00 | 11,463,000.00 | 0.00 | 43,326,000.00 | 130,445,000.00 | 641,578,000.00 | 19,663,000.00 | 621,915,000.00 | 32,673,000.00 | 1,713,966,000.00 | -1,000.00 | 0.00 | 721,817,000.00 | 13,235,000.00 | 708,582,000.00 | 184,742,000.00 | 4,427,000.00 | 761,252,000.00 | 105,847,000.00 | 3,082,000.00 | 7,122,000.00 | 645,201,000.00 | 12,237,305,000.00 | 5,196,222,000.00 | 81,094,000.00 | 130,024,000.00 | 484,253,000.00 | 484,253,000.00 | 0.00 | 94,034,000.00 | 94,034,000.00 | 45,282,000.00 | 514,086,000.00 | 228,275,000.00 | 285,811,000.00 | 3,910,175,000.00 | -2,728,924,000.00 | 6,639,099,000.00 | 147,446,000.00 | 21,658,000.00 | 5,123,850,000.00 | 849,166,000.00 | 496,979,000.00 | 0.00 | 7,041,083,000.00 | 165,819,000.00 | 3,082,000.00 | 119,181,000.00 | 1,264,820,000.00 | 53,808,000.00 | 236,590,000.00 | 234,200,000.00 | 740,222,000.00 | 94,544,000.00 | 92,330,000.00 | 1,558,631,000.00 | -4,376,000.00 | 1,563,007,000.00 | 3,742,676,000.00 | 3,693,130,000.00 | 49,546,000.00 | 0.00 | 49,546,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: POLYMED Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Long Term Debt Issuance | Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Dividends Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Pension And Employee Benefit Expense | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -109,337,000.00 | 0.00 | 2,638,000.00 | -2,770,159,000.00 | 120,531,000.00 | 0.00 | 70,624,000.00 | 49,907,000.00 | -201,535,000.00 | -110,240,000.00 | -287,400,000.00 | 0.00 | 2,638,000.00 | 2,638,000.00 | 211,196,000.00 | 211,196,000.00 | 0.00 | -2,409,380,000.00 | 0.00 | 131,770,000.00 | 5,426,000.00 | 204,420,000.00 | 0.00 | 0.00 | -2,750,996,000.00 | 19,163,000.00 | -2,770,159,000.00 | 2,660,822,000.00 | -743,013,000.00 | -406,570,000.00 | 91,273,000.00 | -47,241,000.00 | 37,615,000.00 | -123,756,000.00 | -366,856,000.00 | -60,392,000.00 | 11,262,000.00 | 639,265,000.00 | 34,911,000.00 | 604,354,000.00 | 21,144,000.00 | -209,488,000.00 | -14,409,000.00 | -6,228,000.00 | 3,442,691,000.00 |
| 2023-03-31T00:00:00 | annual | -482,228,000.00 | 0.00 | 3,513,000.00 | -2,392,748,000.00 | 70,624,000.00 | -1,000.00 | 77,574,000.00 | -6,949,000.00 | -125,053,000.00 | -84,575,000.00 | -239,730,000.00 | 0.00 | 3,513,000.00 | 3,513,000.00 | 209,899,000.00 | 209,899,000.00 | 0.00 | -1,792,416,000.00 | -1,000.00 | 15,831,000.00 | 5,386,000.00 | 577,638,000.00 | 0.00 | 0.00 | -2,391,271,000.00 | 1,477,000.00 | -2,392,748,000.00 | 1,910,520,000.00 | -578,669,000.00 | -494,597,000.00 | 157,044,000.00 | -11,261,000.00 | 37,692,000.00 | -402,905,000.00 | -287,968,000.00 | -26,773,000.00 | 5,939,000.00 | 571,668,000.00 | 29,194,000.00 | 542,474,000.00 | 19,274,000.00 | 40,069,000.00 | 17,545,000.00 | -1,003,000.00 | 2,374,914,000.00 |
| 2022-03-31T00:00:00 | annual | -321,055,000.00 | 0.00 | 989,000.00 | -1,555,777,000.00 | 77,574,000.00 | 1,000.00 | 49,546,000.00 | 28,027,000.00 | -353,379,000.00 | -40,996,000.00 | -239,156,000.00 | 0.00 | 989,000.00 | 989,000.00 | -62,816,000.00 | -62,816,000.00 | 0.00 | -853,316,000.00 | 0.00 | 38,700,000.00 | 3,189,000.00 | 645,432,000.00 | 0.00 | 0.00 | -1,540,637,000.00 | 15,140,000.00 | -1,555,777,000.00 | 1,234,722,000.00 | -474,560,000.00 | -633,944,000.00 | 119,269,000.00 | -80,250,000.00 | 247,015,000.00 | -418,823,000.00 | -507,356,000.00 | -110,665,000.00 | 308,000.00 | 539,522,000.00 | 26,784,000.00 | 512,738,000.00 | 9,310,000.00 | -101,210,000.00 | -24,526,000.00 | -5,305,000.00 | 1,952,449,000.00 |
| 2021-03-31T00:00:00 | annual | 236,006,000.00 | 0.00 | 4,000,000,000.00 | -951,312,000.00 | 49,546,000.00 | -1,000.00 | 48,574,000.00 | 973,000.00 | 3,169,485,000.00 | -85,247,000.00 | 0.00 | 0.00 | 4,000,000,000.00 | 4,000,000,000.00 | -664,518,000.00 | -664,518,000.00 | 0.00 | -4,355,830,000.00 | 0.00 | 27,644,000.00 | 5,979,000.00 | -3,444,285,000.00 | 0.00 | -3,444,285,000.00 | -945,168,000.00 | 6,144,000.00 | -951,312,000.00 | 1,187,318,000.00 | -446,212,000.00 | -611,854,000.00 | -28,439,000.00 | -102,701,000.00 | 595,000.00 | -143,871,000.00 | -332,293,000.00 | 31,938,000.00 | 2,996,000.00 | 475,220,000.00 | 24,988,000.00 | 450,232,000.00 | 6,473,000.00 | -56,712,000.00 | 16,309,000.00 | -72,000.00 | 1,800,540,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 332,948,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -424,746,000.00 | -424,746,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 332,948,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 81,825,000.00 | -150,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: POLYMED Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Research And Development | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 5.79 | 0.00 | 397.05 | 23.00 | 23.00 | 258.26 | 63.93 | 604.32 | 420.05 | 356.13 | -2.89 | 11.86 | 11.84 | 241.05 | 258.26 | 1,063.04 | 2.23 | 9.60 | 9.59 | 0.00 | 0.00 | 258.26 | 258.26 | 0.00 | 258.26 | 0.00 | 258.26 | 258.26 | 86.01 | 344.27 | 3.32 | -0.56 | -0.62 | 1.18 | -2.89 | 2.86 | 11.86 | 11.84 | 302.65 | 458.72 | 92.26 | 63.93 | 3.49 | 60.44 | 18.96 | 47.32 | 26.37 | 20.96 | 2.23 | 761.38 | 604.32 | 1,365.69 | 1,365.69 |
| 2023-03-31T00:00:00 | annual | -1.00 | 0.00 | 307.25 | -4.05 | -4.05 | 179.28 | 57.17 | 509.32 | 303.20 | 246.03 | -4.88 | 8.54 | 5.97 | 182.33 | 179.28 | 890.81 | 1.93 | 9.60 | 9.59 | 0.00 | 0.00 | 179.28 | 179.28 | 0.00 | 179.28 | 0.00 | 179.28 | 179.28 | 58.21 | 237.49 | 3.30 | -0.04 | -0.10 | 0.14 | -4.88 | 2.31 | 8.54 | 5.97 | 217.85 | 381.49 | 72.18 | 57.17 | 2.92 | 54.25 | 17.80 | 38.09 | 20.51 | 17.57 | 1.93 | 599.34 | 509.32 | 1,108.66 | 1,108.66 |
| 2022-03-31T00:00:00 | annual | 2.39 | 0.00 | 243.45 | 9.47 | 9.47 | 146.51 | 53.95 | 433.23 | 252.92 | 198.97 | -3.87 | 3.72 | 2.29 | 139.43 | 146.51 | 752.83 | 2.24 | 9.60 | 9.59 | 0.00 | 0.00 | 146.51 | 146.51 | 0.00 | 146.51 | 0.00 | 146.51 | 146.51 | 48.74 | 195.24 | 3.65 | -0.13 | -0.53 | 0.66 | -3.87 | 2.44 | 3.72 | 2.29 | 164.05 | 319.61 | 55.99 | 53.95 | 2.68 | 51.27 | 18.77 | 32.24 | 15.08 | 17.16 | 2.24 | 483.66 | 433.23 | 916.89 | 916.89 |
| 2021-03-31T00:00:00 | annual | 0.84 | 0.00 | 231.97 | 3.34 | 3.34 | 135.87 | 47.52 | 336.46 | 235.31 | 187.79 | -7.27 | 7.74 | 3.37 | 133.37 | 135.87 | 604.78 | 2.22 | 8.92 | 8.91 | 0.00 | 0.00 | 135.87 | 135.87 | 0.00 | 135.87 | 0.00 | 135.87 | 135.87 | 44.18 | 180.05 | 1.23 | -0.17 | -0.01 | 0.18 | -7.27 | 2.90 | 7.74 | 3.37 | 170.26 | 268.31 | 45.72 | 47.52 | 2.50 | 45.02 | 13.14 | 29.46 | 12.63 | 16.83 | 2.22 | 438.57 | 336.46 | 775.04 | 775.04 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
6/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
30.63
P/E
83.64513
P/B
9.596988
Dividend Yield
0.12%
Market Cap
25,980.21 Cr.
Face Value
266.964
Book Value
266.964
ROE
19.37%
EBITDA Growth
405.52 Cr.
Debt/Equity
6.199
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of polymed?
The market capitalization of Poly Medicure Limited is ₹25,980 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Poly Medicure Limited?
The PE and PB ratios of Poly Medicure Limited are Not Available and 9.596988 respectively as of 05 Feb 2025.
What is the 52 Week High of Poly Medicure Limited?
The 52-week high of Poly Medicure Limited is ₹3357.8 as of 05 Feb 2025.
What is the 52 Week Low of Poly Medicure Limited?
The 52-week low of Poly Medicure Limited is ₹1361 as of 05 Feb 2025.
What are the earnings per share (EPS) for Poly Medicure Limited?
The Earnings Per Share (EPS) of Poly Medicure Limited is ₹30.63 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Poly Medicure Limited?
The Return on Equity (ROE) of Poly Medicure Limited is 19.37% as per the most recent financial year data. Explore more on Fincept.